Tiziana Life Sciences Statistics
Total Valuation
TLSA has a market cap or net worth of $163.85 million. The enterprise value is $160.23 million.
Important Dates
The next estimated earnings date is Tuesday, July 22, 2025, before market open.
| Earnings Date | Jul 22, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TLSA has 111.46 million shares outstanding. The number of shares has increased by 4.10% in one year.
| Current Share Class | 111.46M |
| Shares Outstanding | 111.46M |
| Shares Change (YoY) | +4.10% |
| Shares Change (QoQ) | +6.93% |
| Owned by Insiders (%) | 43.13% |
| Owned by Institutions (%) | 2.74% |
| Float | 63.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 41.63 |
| P/TBV Ratio | 41.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.02 |
| Quick Ratio | 1.00 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -250.49% and return on invested capital (ROIC) is -200.94%.
| Return on Equity (ROE) | -250.49% |
| Return on Assets (ROA) | -84.13% |
| Return on Invested Capital (ROIC) | -200.94% |
| Return on Capital Employed (ROCE) | -401.27% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.32M |
| Employee Count | 9 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -4.88M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +81.93% in the last 52 weeks. The beta is 0.16, so TLSA's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | +81.93% |
| 50-Day Moving Average | 1.49 |
| 200-Day Moving Average | 1.10 |
| Relative Strength Index (RSI) | 46.42 |
| Average Volume (20 Days) | 197,507 |
Short Selling Information
| Short Interest | 473,548 |
| Short Previous Month | 596,494 |
| Short % of Shares Out | 0.77% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.95 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -15.79M |
| Pretax Income | -17.24M |
| Net Income | -11.86M |
| EBITDA | -15.78M |
| EBIT | -15.79M |
| Earnings Per Share (EPS) | -$0.11 |
Full Income StatementBalance Sheet
The company has $3.72 million in cash and $106,000 in debt, giving a net cash position of $3.62 million or $0.03 per share.
| Cash & Cash Equivalents | 3.72M |
| Total Debt | 106,000 |
| Net Cash | 3.62M |
| Net Cash Per Share | $0.03 |
| Equity (Book Value) | 3.94M |
| Book Value Per Share | 0.04 |
| Working Capital | 160,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$1.53 million and capital expenditures -$19,000, giving a free cash flow of -$1.55 million.
| Operating Cash Flow | -1.53M |
| Capital Expenditures | -19,000 |
| Free Cash Flow | -1.55M |
| FCF Per Share | -$0.01 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
